HBcrAg-based risk score performs better than the HBV DNA-based scores for HCC prediction in grey zone patients who are HBeAg-negative

TAI-CHUNG TSENGHosaka, TetsuyaTetsuyaHosakaCHUN-JEN LIUSuzuki, FumitakaFumitakaSuzukiChiang, ChiehChiehChiangCHUN-MING HONGKumada, HiromitsuHiromitsuKumadaYang, Wan-TingWan-TingYangTUNG-HUNG SUHUNG-CHIH YANGCHEN-HUA LIUPEI-JER CHENJIA-HORNG KAO2024-01-092024-01-092024-0125895559https://scholars.lib.ntu.edu.tw/handle/123456789/638269Risk scores have been designed to predict the development of hepatocellular carcinoma (HCC) in treatment-naive patients with chronic hepatitis B (CHB). However, little is known about their predictive accuracy in HBeAg-negative patients in the grey zone (GZ). We aimed to develop a HBcrAg-based HCC risk score and explore whether it outperforms other risk scores in GZ patients.enERADICATE-B; Grey zone; HBcrAg; HCC; Hepatocellular carcinoma[SDGs]SDG3HBcrAg-based risk score performs better than the HBV DNA-based scores for HCC prediction in grey zone patients who are HBeAg-negativejournal article10.1016/j.jhepr.2023.100956380895512-s2.0-85179434321